Quote:We can mass test the UK out of Covid lockdowns,’ says Innova
The boss of the world’s biggest supplier of rapid Covid-19 tests has declared that frequent mass testing is feasible and could be the key to unlocking the economy.
Daniel Elliott, of Innova Medical Group, said the UK was his biggest customer, with hundreds of millions of tests already delivered and a total of one billion expected by the middle of next month.
The UK has agreed to buy at least £2.8 billion of Innova’s rapid lateral flow test kits, which give a result within 30 minutes. Under the Operation Moonshot strategy, the government plans to use targeted mass testing in the public sector to monitor infection rates and stop asymptomatic spread.
Elliott, who is scaling up production to 50 million tests a day, said about half of Innova’s customers were companies that want to protect employees in the workplace.
“There’s a significant amount in warehouses around the country,” he said. “Now it’s going to be schools, and, ultimately, opening up the country in other ways — haircuts, restaurants and things like that.”
It is understood that the investment bank Citigroup is using Innova’s tests in America and is preparing to test staff at its tower in London’s Canary Wharf, where about 6,000 worked before the pandemic.
James Bardrick, Citi’s UK chief, said a pilot scheme would begin tomorrow for people who are unable to work from home and are approved to go into the office. The scheme will be voluntary.
“Other banks are following and we’re in discussions with more,” said Elliott.
Innova’s optimism on UK test numbers comes as the mood among businesses appears to be shifting. Last month, David Solomon, the chief executive of Goldman Sachs, said home working was “not a new normal”, and Barclays boss Jes Staley said it was “getting old”.
In an interview in The Sunday Times today, Dominic Blakemore, chief executive of catering giant Compass, says: “The mood is generally that people want to be in the office and together more than they are apart.”
Elliott said Innova was delivering “millions of tests to the UK every single day”, and it was the intention of the government to eventually roll them out to sports events, concerts and leisure venues.
Innova, which is based in California and owned by the private equity firm Pasaca Capital, is in discussions with pharmacy chains in the UK to sell direct to consumers. It is building a factory in this country to satisfy demand.
Elliott said a mass-testing strategy was “most protective in businesses like personal care, pubs, clubs and a lot of events ... where close contact in enclosed spaces can’t be avoided”.
In the past, the Medicines and Healthcare Products Regulatory Agency raised concerns about lateral flow tests. However, it issued an exceptional-use authorization in December permitting NHS Test and Trace to send Innova’s kits to asymptomatic people for self-testing.
“Eventually the pandemic will end in some fashion and we’ll have to do regular testing for some period of time,” said Elliott. “Lots of things affect the results but a good rule of thumb is to test as many people as possible twice a week.
Found the full article. HIGHLY recommend reading it: We
Top 10 Most Recent News Articles
Core Natural Resources Strikes Gold in Q3, Surpassing Targets
Core's Strong Q3: A Closer Look The latest buzz in the coal sector is all about Core Natural Resources, Inc. (NYSE: CNR) delivering a sturdy third quarter performance. These folks are playing the market like a fiddle, dishing out $9 million in net income and clocking $165.2 million in adjusted EBITDA. For a sector rife with dust and sweat, that's not too shabby. A Closer...
Continue Reading
S&P 500 Drop: A Market Glitch or Future Trend?
A Sudden Jolt in a Trending Market Mornings like these make you question your coffee strength. A major market dip, with the S&P 500 shedding 3.51%, is like a slap to the face, especially when the Nasdaq Composite takes a 5.24% nosedive. The Dow isn't spared, dropping 2.45%. But, let's not lose our heads here. Today is a blip, a pixel in the bigger picture where the S&P...
Continue Reading
Pavlus Travel's Bucket-List Trips in High Demand for 2027
Luxury Travel is Having a Moment A fancy vacation isn't just a postcard on the wall anymore—it's now, more than ever, a box folks are itching to check off their lists. Call it a midlife shift or just the world shrugging off its pandemic blues, but high-end travelers are saying, "The time is now," and they're serious. Pavlus Travel, a top name in the lux travel space,...
Continue Reading
Energy Fuels' Bold Moves: An Investor's Analysis
Energy Fuels Sets the Stage An era of rare earths and uranium dominance—this is the gauntlet Energy Fuels seems to be throwing down. With the acquisition of ASM and a Korean Metals Plant under its belt, they're flexing a strategy designed to boost the west's autonomous rare earth supply chain. That ain't a small feat, and it looks like they're gearing up for a battle...
Continue Reading
Endava Faces Class Action for Securities Violation
Endava's Legal Storm Clouds Gather Well, well, looks like Endava plc (NYSE: DAVA) has found itself knee-deep in a legal quagmire, thanks to some not-so-transparent financial antics. Investors are up in arms, and the fine folks at DJS Law Group are stepping in, filing a class action lawsuit against Endava for overstating their financial health. They allege that Endava made...
Continue Reading
Fedora and Clarion Boost Oncology Practice Performance
Hell of a Pair-Up: Fedora and Clarion Focus on Oncology Well, here's a setup that doesn't scream about blue chip stocks—but it's swimming in opportunity all the same. Fedora Healthcare Solutions just shook hands with Clarion, cementing a deal that's piqued my interest for its potential to green-light some real progress for independent oncology practices. These are not...
Continue Reading
Perpetua's Bold Moves Elevate Idaho's Stibnite Gold Project
Perpetua Resources Sparking New Conversations Alright, fasten your seatbelts, folks—Perpetua Resources is causing a buzz with its Stibnite Gold Project. If you blink, you might miss what's happening down in Idaho. They've started throwing some serious weight around with fresh gold discoveries that not only promise ounces but maybe some juicy returns for those keeping a...
Continue Reading
Minesto's Tidal Project Nets EU Recognition & Funding
Tapping Into the Tides: Minesto's Strategic Leap Table flipping news coming in from Gothenburg! Minesto—the ocean energy trailblazer—is making waves again, snagging the EU's STEP Seal for its Euro Dragon Farm project in Ireland. You couldn't ask for a better boon from Brussels—they're sinking a cool EUR 20.2 million in grant funds into this tidal energy venture....
Continue Reading
Admetec Shines Bright with New High-Magnification Headlights
Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...
Continue Reading
Implantica's RefluxStop® Makes U.S. Debut with a Bang
A Fresh Chapter in U.S. Medtech There’s a new kid on the block, folks, and it's making waves in the medtech scene. Implantica has just announced the successful completion of their first RefluxStop® procedures in the good ol' U.S. of A. That's right, we've got another player in the game aiming to shake things up, and frankly, it's about time someone brought a fresh...
Continue ReadingTop 5 Most Recently Viewed Articles
THEON Achieves Landmark NVG Contract with OCCAR, €1 Billion Deal
Historic Contract for Night Vision Goggles Signed by THEON Taking a significant step in the realm of military technology, THEON International Plc (THEON) has recently secured a groundbreaking contract amendment with OCCAR, creating a firm order for 100,000 Night Vision Goggles (NVGs) for the German Bundeswehr. Additionally, the Belgian Armed Forces have exercised an...
Continue Reading
Will Nvidia's Earnings Ignite Super Micro's Stock Recovery?
Super Micro Computer Inc: Acknowledging Current Performance Super Micro Computer Inc (NASDAQ: SMCI) finds itself at a crossroads, currently trading above $44. This represents a significant drop of 27% over the last month and over 22% versus the last year. In stark contrast, the excitement surrounding Nvidia Corp's (NASDAQ: NVDA) upcoming earnings poses questions about...
Continue Reading
C21 Investments Initiates Share Buyback Program for Growth
C21 Investments Initiates Share Buyback Program to Enhance Value C21 Investments Inc. (CSE: CXXI, OTCQX: CXXIF), a prominent vertically integrated cannabis company, has announced a new strategy to enhance shareholder value through the commencement of a normal course issuer bid (NCIB). This initiative allows the company to repurchase up to 6,002,390 of its common shares,...
Continue Reading
Heimar hf. Expands Portfolio with Gróska Acquisition Deal
Heimar hf. Expands Portfolio with Gróska Acquisition Deal Heimar hf. has taken a significant step by reaching an agreement to acquire all shares in Gróska ehf. and Gróðurhúsið ehf. This strategic acquisition is set to bolster Heimar's portfolio and enhance its position in the market. Details of the Gróska Acquisition Gróska is recognized as a major player in the...
Continue Reading
How Advanced Tech is Reshaping Digital Asset Recovery Services
Transforming Digital Asset Recovery Through Technology The landscape of digital asset recovery is evolving rapidly, thanks to the advancements in blockchain and computational technology. These innovations are instrumental in making the recovery process more effective and efficient. The Role of Leading Companies At the forefront of this transformation is Broker Complaint...
Continue Reading